AU1593197A - Process for preparing ganciclovir derivatives - Google Patents

Process for preparing ganciclovir derivatives

Info

Publication number
AU1593197A
AU1593197A AU15931/97A AU1593197A AU1593197A AU 1593197 A AU1593197 A AU 1593197A AU 15931/97 A AU15931/97 A AU 15931/97A AU 1593197 A AU1593197 A AU 1593197A AU 1593197 A AU1593197 A AU 1593197A
Authority
AU
Australia
Prior art keywords
derivatives
preparing
preparing ganciclovir
ganciclovir derivatives
ganciclovir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15931/97A
Other languages
English (en)
Inventor
Humberto B. Arzeno
Eric R Humphreys
Christopher R. Roberts
Jim-Wah Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU1593197A publication Critical patent/AU1593197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU15931/97A 1996-01-26 1997-01-20 Process for preparing ganciclovir derivatives Abandoned AU1593197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59228296A 1996-01-26 1996-01-26
US592282 1996-01-26
PCT/EP1997/000238 WO1997027197A1 (en) 1996-01-26 1997-01-20 Process for preparing ganciclovir derivatives

Publications (1)

Publication Number Publication Date
AU1593197A true AU1593197A (en) 1997-08-20

Family

ID=24370063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15931/97A Abandoned AU1593197A (en) 1996-01-26 1997-01-20 Process for preparing ganciclovir derivatives

Country Status (7)

Country Link
US (2) US5840890A (enExample)
EP (1) EP0885224B1 (enExample)
JP (1) JP4094666B2 (enExample)
AU (1) AU1593197A (enExample)
DE (1) DE69717974T2 (enExample)
ES (1) ES2187752T3 (enExample)
WO (1) WO1997027197A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040446A (en) * 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
KR20000053226A (ko) * 1996-11-12 2000-08-25 요나스 프릭 뉴클레오사이드
CA2457835A1 (en) * 2001-09-07 2003-03-20 Teva Pharmaceutical Industries Ltd. Crystalline forms of valacyclovir hydrochloride
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20070129385A1 (en) * 2003-08-28 2007-06-07 Sharma Mukesh K Amorphous valganciclovir hydrochloride
JP2007513074A (ja) * 2004-09-04 2007-05-24 テバ ファーマシューティカル インダストリーズ リミティド 単離されたバラシクロビル不純物、バラシクロビル不純物の調製方法および参照標準としての使用
DK1853675T3 (da) * 2005-01-25 2011-08-22 Sigma Coatings Bv Binderpræparat
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
EP1870411B1 (en) * 2006-06-21 2016-03-16 Fidia Farmaceutici S.p.A. Process for the preparation and purification of valgancyclovir
CA2671470C (en) 2006-12-13 2012-05-01 F. Hoffmann-La Roche Ag Powder formulation for valganciclovir
US20090076040A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched valganciclovir
WO2010036904A2 (en) * 2008-09-26 2010-04-01 Dr. Reddy's Laboratories Ltd. Preparation of valganciclovir and its salts
IT1397233B1 (it) * 2010-01-08 2013-01-04 Fidia Farmaceutici Procedimento migliorativo per la sintesi del mono-acetil ganciclovir, intermedio chiave per la sintesi del valganciclovir.
CN101955481B (zh) * 2010-10-09 2016-04-20 广东肇庆星湖生物科技股份有限公司 一种盐酸缬更昔洛韦的制备方法
EP2714691B1 (en) * 2011-05-31 2016-09-07 Pharmathen S.A. Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir
CN105732630B (zh) * 2016-04-20 2018-11-30 安徽海康药业有限责任公司 一种cbz-缬更昔洛韦的制备方法
CN105693722B (zh) * 2016-04-20 2018-07-20 安徽海康药业有限责任公司 一种cbz-缬更昔洛韦的制备方法
CN105693724B (zh) * 2016-04-20 2017-08-11 安徽海康药业有限责任公司 一种cbz‑缬更昔洛韦的制备方法
CN112409359A (zh) * 2020-11-30 2021-02-26 沃德药业(安徽)股份有限公司 一种盐酸缬更昔洛韦制备方法
CN113880838B (zh) * 2021-11-15 2024-03-19 仁合益康集团有限公司 一种微通道反应器合成盐酸缬更昔洛韦的方法
CN115286632B (zh) * 2022-09-16 2023-05-09 河北医科大学 一种盐酸缬更昔洛韦的制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
PT75406B (en) * 1981-08-11 1985-11-15 Wellcome Found Antiviral compounds
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3376326D1 (en) * 1982-10-14 1988-05-26 Wellcome Found Antiviral purine derivatives
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
ATE123285T1 (de) * 1988-12-19 1995-06-15 Wellcome Found Antivirale pyrimidin- und purinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
GB8829571D0 (en) 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5831075A (en) * 1993-06-10 1998-11-03 Rolabo Sl Amino acid ester of nucleoside analogues
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives

Also Published As

Publication number Publication date
DE69717974T2 (de) 2003-10-02
WO1997027197A1 (en) 1997-07-31
EP0885224B1 (en) 2002-12-18
US5840890A (en) 1998-11-24
DE69717974D1 (de) 2003-01-30
JP4094666B2 (ja) 2008-06-04
JP2000505080A (ja) 2000-04-25
US6103901A (en) 2000-08-15
EP0885224A1 (en) 1998-12-23
ES2187752T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
AU1593197A (en) Process for preparing ganciclovir derivatives
AU697684B2 (en) Process for preparing sildenafil
AU1542697A (en) Process for preparing purine derivatives
AU5684596A (en) Process for preparing 4-aryl-piperidine derivatives
AU3092297A (en) Process for preparing bitument compositions
AU5317398A (en) Method for preparing cyclopropylamines
AU1986997A (en) Process for preparing sulfoxides
AU7577396A (en) New preparation process for phenylimidazolidine derivatives
AU1592997A (en) Process for preparing purine derivatives
AUPN772896A0 (en) Process for preparing optical articles
IL118992A (en) Process for preparing norbenzomorphan derivatives
AU1592897A (en) Process for preparing purine derivatives
AU3255997A (en) Process for preparing 1,3-alkanediols
AU4958397A (en) Process for making benzisothiazolin-3-ones
AU1370497A (en) Process for preparing 4-aminopteridine derivatives
AU7562996A (en) Process for preparing dioxoazabicyclohexanes
AU4151297A (en) Novel process for preparing camptothecin
AU4233997A (en) Process for preparing pharmaceutical compounds
AU3746595A (en) Method for preparing poly-p-diisopropylbenzene
AU8799298A (en) Process for preparing nifedipine
AU3438397A (en) Process for preparing pyrazolone derivatives
AU8549398A (en) Process for preparing 3-isochromanone
AU4724797A (en) Novel process for preparing fr900482 and compounds analogous thereto
AU5188198A (en) Process for the preparation of tetrahydro-5-oxo-pyrrolizine derivatives
AU2737395A (en) Process for preparing benzothiophene derivatives